The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Two inhibitors of pro‐inflammatory cytokine release, interleukin‐10 and interleukin‐4, have contrasting effects on release of soluble p75 tumor necrosis factor receptor by cultured monocytes
Abstract
The biological activity of the pro‐inflammatory cytokine, tumor necrosis factor (TNF)‐α depends on the level of TNF‐α itself, the expression of the p55 and p75 cell surface receptors for TNF on target cells and the concentrations of the natural inhibitors of TNF‐α, the soluble p55 and p75 TNF receptors (TNF‐R). Interleukin (IL)‐10 and IL‐4 are known to inhibit TNF‐α production by monocytes. We, therefore, investigated the effects of IL‐10 and IL‐4 on the cell surface expression and release of TNF‐R by human monocytes to determine whether these cytokines also indirectly modulated the biological activity of TNF‐α. Exposure to IL‐10 (1‐10 U/ml) for 24 or 48 h increased soluble p75 TNF‐R expression and concomitantly reduced surface expression of p75 TNF‐R. Further, IL‐l α‐stimulated production of TNF‐α was diminished by IL‐10 and only a small proportion of this TNF‐α was bioactive, consistent with increased production of inhibitory soluble TNF‐R. IL‐10 also induced down‐regulation of surface p55 TNF‐R on monocytes, and increased release of soluble p55 TNF‐R. However, the expression of soluble p55 TNF‐R was much lower than soluble p75 TNF‐R, indicating that it contributed less importantly to neutralization of TNF‐α under these conditions. Like IL‐10, IL‐4 supressed the release of TNF‐α by monocytes. In contrast to IL‐10, however, IL‐4 (0.1‐10 ng/ml) supressed the release of soluble p75 TNF‐R from monocytes in a dose‐dependent manner. Release of soluble p55 TNF‐R was also supressed by IL‐4. IL‐10, therefore, reduces the pro‐inflammatory potential of TNF in three ways: by down‐regulating surface TNF‐R expression whilst increasing production of soluble TNF‐R and inhibiting the release of TNF‐α itself. This suggests that IL‐10 may be useful in the treatment of diseases where overexpression of TNF‐α occurs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
de Waal Malefyt, R., Abrams, J., Bennett, B., Figdor, C. G., & de Vries, J. E. (1991) · The Journal of experimental medicine · doi:10.1084/jem.174.5.1209 · Cited by 3,762
Cited by
ROLE OF CYTOKINES IN RHEUMATOID ARTHRITIS
Feldmann, M., Brennan, F. M., & Maini, R. N. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.397 · Cited by 2,514
Self-citationOpal, S. M., & DePalo, V. A. (2000) · Chest · doi:10.1378/chest.117.4.1162 · Cited by 1,752
IL-6 enhances plasma IL-1ra, IL-10, and cortisol in humans
Steensberg, A., Fischer, C. P., Keller, C., Møller, K., & Pedersen, B. K. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00074.2003 · Cited by 1,135
Sabat, R., Grütz, G., Warszawska, K., Kirsch, S., Witte, E., Wolk, K., & Geginat, J. (2010) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2010.09.002 · Cited by 977
Interleukin-10 Therapy—Review of a New Approach
Asadullah, K., Sterry, W., & Volk, H. D. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.2.4 · Cited by 946
A Review: Inflammatory Process in Alzheimer's Disease, Role of Cytokines
Rubio-Perez, J. M., & Morillas-Ruiz, J. M. (2012) · The Scientific World Journal · doi:10.1100/2012/756357 · Cited by 839
Regulation of serum amyloid A protein expression during the acute-phase response
JENSEN, L. E., & WHITEHEAD, A. S. (1998) · Biochemical Journal · doi:10.1042/bj3340489 · Cited by 411
Williams, L., Bradley, L., Smith, A., & Foxwell, B. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.1.567 · Cited by 393
Opp, M. R. (2005) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2005.01.002 · Cited by 393
Anti-Cytokine Therapy for Rheumatoid Arthritis
Maini, R. N., & Taylor, P. C. (2000) · Annual Review of Medicine · doi:10.1146/annurev.med.51.1.207 · Cited by 376
An immune-based biomarker signature is associated with mortality in COVID-19 patients
Abers, M. S., Delmonte, O. M., Ricotta, E. E., Fintzi, J., Fink, D. L., de Jesus, A. A. A., Zarember, K. A., Alehashemi, S., Oikonomou, V., Desai, J. V., et al. (2021) · JCI Insight · doi:10.1172/jci.insight.144455 · Cited by 340
The complex role of adipokines in obesity, inflammation, and autoimmunity
Taylor, E. B. (2021) · Clinical Science · doi:10.1042/cs20200895 · Cited by 330
The Cytokine Response to Physical Activity and Training
Moldoveanu, A. I., Shephard, R. J., & Shek, P. N. (2001) · Sports Medicine · doi:10.2165/00007256-200131020-00004 · Cited by 325
Balcewicz-Sablinska, M. K., Keane, J., Kornfeld, H., & Remold, H. G. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.5.2636 · Cited by 318
Endogenous IL-10 protects mice from death during septic peritonitis
van der Poll, T., Marchant, A., Buurman, W. A., Berman, L., Keogh, C. V., Lazarus, D. D., Nguyen, L., Goldman, M., Moldawer, L. L., & Lowry, S. F. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.11.5397 · Cited by 285
Foey, A. D., Parry, S. L., Williams, L. M., Feldmann, M., Foxwell, B. M. J., & Brennan, F. M. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.2.920 · Cited by 283
Self-citationKnoblach, S. M., & Faden, A. I. (1998) · Experimental Neurology · doi:10.1006/exnr.1998.6877 · Cited by 263
Ohtsuka, T., Hamada, M., Hiasa, G., Sasaki, O., Suzuki, M., Hara, Y., Shigematsu, Y., & Hiwada, K. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)01121-9 · Cited by 253
Cytokines and their role in the pathophysiology of osteoarthritis
Martel-Pelletier, J. (1999) · Frontiers in Bioscience · doi:10.2741/a387 · Cited by 253
Interleukin-10 potential benefits and possible risks in clinical infectious diseases
Opal, S. M., Wherry, J. C., & Grint, P. (1998) · Clinical Infectious Diseases · doi:10.1086/515032 · Cited by 114
Madecassoside attenuates inflammatory response on collagen-induced arthritis in DBA/1 mice
Li, H., Gong, X., Zhang, L., Zhang, Z., Luo, F., Zhou, Q., Chen, J., & Wan, J. (2009) · Phytomedicine · doi:10.1016/j.phymed.2008.11.002 · Cited by 85
Efficacy and mechanism of cGAMP to suppress Alzheimer’s disease by elevating TREM2
Xu, Q., Xu, W., Cheng, H., Yuan, H., & Tan, X. (2019) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2019.07.004 · Cited by 75
Association between corrected QT interval and inflammatory cytokines in rheumatoid arthritis
Adlan, A. M., Panoulas, V. F., Smith, J. P., Fisher, J. P., & Kitas, G. D. (2015) · The Journal of Rheumatology · doi:10.3899/jrheum.140861 · Cited by 71
Thévenon, A. D., Zhou, J. A., Megnekou, R., Ako, S., Leke, R. G. F., & Taylor, D. W. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1002293 · Cited by 44
“IL-10, which is elevated in PM (5), has been shown to induce the release of sTNFR2 from monocytes (40).”
Metadata
- Authors
- Joyce, D. A., Gibbons, D. P., Green, P., Steer, J. H., Feldmann, M., & Brennan, F. M.
- Venue
- European Journal of Immunology
- Publisher
- Wiley
- Published
- 1994-11
- Volume
- 24
- Issue
- 11
- Pages
- 2699-2705
- ISSN
- 0014-2980 (ISSN-L)
- 1521-4141
- OpenAlex
- W2149805219
- Cited by
- 206
- References
- 1
- FWCI
- 4.08
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.